Treat migraine like the disease it is this Giving Tuesday
November 28, 2023 FOR IMMEDIATE RELEASE For an estimated 12% (4.5 million) of Canadians, that’s society’s harsh judgment of people living with migraine. Join Migraine Canada as we recognize this disease for what it is. For some, migraine is disabling and debilitating, robbing them from…
Mastermind
Physicians receive little training on migraine in medical school. The Canadian Headache Society (CHS) has developed an accredited online-learning platform on advancing migraine management in primary care. The program has been certified by the College of Family physicians of Canada. All physicians in Canada are…
gammaCore Sapphire Device for Non-Invasive Vagal Nerve Stimulation and Migraine
What is it? The gammaCore Sapphire device is a hand-held device that the patient uses to stimulate the vagus nerve in the neck. How is it used? The device is held against the side of the neck on the side on which the patient has…
Canadian Update: Lasmiditan (Reyvow™ in the US) will not be coming to Canada
An announcement was recently made that lasmiditan, a new medication for the treatment of migraine attacks, developed by Eli Lilly, will not be available in Canada. This news was disappointing as more options are always welcome and needed for people with migraine. Lasmiditan acts on…
gammaCore Sapphire Device for Non-Invasive Vagal Nerve Stimulation and Migraine
What is it? The gammaCore SapphireTM (nVNS) is a hand-held device that the patient uses to stimulate the vagus nerve in the neck. The vagus nerve is an important highway of communication between the body and the brain and plays an important role in regulating…
Migraine Talks Podcast
Dear Friends, Migraine Canada™ is proud to present its latest media production, “Migraine Talks” with Dr. Elizabeth Leroux. Migraine Talks is a series of 12 episodes which you can listen to on MigraineCanada.org, on Apple Podcast, on Google Podcast, and on Spotify! While exploring the basics…
Canadian Clusterbusters : time to unite
The worst pain of all Attacks of excruciating pain around the eye and temple, just on this one side. A hot poker pushed inside your face. Your eye tears, your nose runs. For an hour or two, you are in hell. The attack is brutal,…
Suvexx™ – a new combination product for acute migraine treatment
What is Suvexx? Suvexx is a combination of two commonly used acute migraine medications in a single tablet: sumatriptan 85 mg and naproxen sodium 500 mg. This product has been available in the U.S. for many years under the brand name Treximet. Combining a triptan…
Tips to keep your mental health for physicians…and everyone else!
Inspired from a document by the Psychiatrist Association of Quebec distributed to physicians. But hey, other people can benefit from good advice too! Living during COVID-19 is not easy. Depending on a person’s character, COVID related stressors, confinement settings, and other factors, different feelings can…
Ajovy (fremanezumab) approved by Health Canada
As of April 9th, Health Canada has approved Ajovy for use in Canada. This is great news for people living with migraine! ** ALWAYS discuss with your health care provider when making decisions about medications. What is Ajovy? Ajovy is a monoclonal antibody targeting CGRP….
Another new drug for migraine is likely on its way to Canada.
A completely new type of migraine preventive medication has been developed over the last ten years, one which uses antibodies to stop migraine attacks. These antibodies are similar to the ones that help you fight viruses, like the common cold, but they are made to…
CADTH supports the reimbursement of Botox for Chronic Migraine
Good News! CADTH supports the reimbursement of Botox for Chronic Migraine Botox was approved by Health Canada in 2011, but reimbursement by public payers was difficult to obtain. Following an updated recommendation from CADTH, access is likely to improve for Canadians with Chronic Migraine. What…
